ID   NDUS2_HUMAN             Reviewed;         463 AA.
AC   O75306; D3DVG7; J3KPM7; Q5VTW0; Q969P3; Q9UEV3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   28-JAN-2026, entry version 230.
DE   RecName: Full=NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial;
DE            EC=7.1.1.2 {ECO:0000269|PubMed:22036843, ECO:0000269|PubMed:30922174};
DE   AltName: Full=Complex I-49kD;
DE            Short=CI-49kD;
DE   AltName: Full=NADH-ubiquinone oxidoreductase 49 kDa subunit;
DE   Flags: Precursor;
GN   Name=NDUFS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9647766; DOI=10.1006/bbrc.1998.8882;
RA   Loeffen J., van den Heuvel L., Smeets R., Triepels R., Sengers R.,
RA   Trijbels F., Smeitink J.;
RT   "cDNA sequence and chromosomal localization of the remaining three human
RT   nuclear encoded iron sulphur protein (IP) subunits of complex I: the human
RT   IP fraction is completed.";
RL   Biochem. Biophys. Res. Commun. 247:751-758(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=9585441; DOI=10.1007/s003359900803;
RA   Procaccio V., de Sury R., Martinez P., Depetris D., Rabilloud T.,
RA   Soularue P., Lunardi J., Issartel J.-P.;
RT   "Mapping to 1q23 of the human gene (NDUFS2) encoding the 49-kDa subunit of
RT   the mitochondrial respiratory complex I and immunodetection of the mature
RT   protein in mitochondria.";
RL   Mamm. Genome 9:482-484(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION IN THE NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=12611891; DOI=10.1074/jbc.c300064200;
RA   Murray J., Zhang B., Taylor S.W., Oglesbee D., Fahy E., Marusich M.F.,
RA   Ghosh S.S., Capaldi R.A.;
RT   "The subunit composition of the human NADH dehydrogenase obtained by rapid
RT   one-step immunopurification.";
RL   J. Biol. Chem. 278:13619-13622(2003).
RN   [8]
RP   INTERACTION WITH NDUFAF3.
RX   PubMed=19463981; DOI=10.1016/j.ajhg.2009.04.020;
RA   Saada A., Vogel R.O., Hoefs S.J., van den Brand M.A., Wessels H.J.,
RA   Willems P.H., Venselaar H., Shaag A., Barghuti F., Reish O., Shohat M.,
RA   Huynen M.A., Smeitink J.A.M., van den Heuvel L.P., Nijtmans L.G.;
RT   "Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting
RT   complex I assembly protein, cause fatal neonatal mitochondrial disease.";
RL   Am. J. Hum. Genet. 84:718-727(2009).
RN   [9]
RP   INTERACTION WITH NDUFAF7.
RX   PubMed=20406883; DOI=10.1242/jcs.066076;
RA   Carilla-Latorre S., Gallardo M.E., Annesley S.J., Calvo-Garrido J.,
RA   Grana O., Accari S.L., Smith P.K., Valencia A., Garesse R., Fisher P.R.,
RA   Escalante R.;
RT   "MidA is a putative methyltransferase that is required for mitochondrial
RT   complex I function.";
RL   J. Cell Sci. 123:1674-1683(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   METHYLATION AT ARG-118, AND INTERACTION WITH NDUFAF7.
RX   PubMed=24089531; DOI=10.1074/jbc.m113.518803;
RA   Rhein V.F., Carroll J., Ding S., Fearnley I.M., Walker J.E.;
RT   "NDUFAF7 methylates arginine 85 in the NDUFS2 subunit of human complex I.";
RL   J. Biol. Chem. 288:33016-33026(2013).
RN   [12]
RP   METHYLATION AT ARG-118.
RX   PubMed=24838397; DOI=10.1093/hmg/ddu239;
RA   Zurita Rendon O., Silva Neiva L., Sasarman F., Shoubridge E.A.;
RT   "The arginine methyltransferase NDUFAF7 is essential for complex I assembly
RT   and early vertebrate embryogenesis.";
RL   Hum. Mol. Genet. 23:5159-5170(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   INVOLVEMENT IN LHONAR2, VARIANTS LHONAR2 CYS-53 AND CYS-308,
RP   CHARACTERIZATION OF VARIANTS LHONAR2 CYS-53 AND CYS-308, AND FUNCTION.
RX   PubMed=28031252; DOI=10.1136/jmedgenet-2016-104212;
RA   Gerber S., Ding M.G., Gerard X., Zwicker K., Zanlonghi X., Rio M.,
RA   Serre V., Hanein S., Munnich A., Rotig A., Bianchi L., Amati-Bonneau P.,
RA   Elpeleg O., Kaplan J., Brandt U., Rozet J.M.;
RT   "Compound heterozygosity for severe and hypomorphic NDUFS2 mutations cause
RT   non-syndromic LHON-like optic neuropathy.";
RL   J. Med. Genet. 54:346-356(2017).
RN   [16]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=30922174; DOI=10.1161/circresaha.118.314284;
RA   Dunham-Snary K.J., Wu D., Potus F., Sykes E.A., Mewburn J.D., Charles R.L.,
RA   Eaton P., Sultanian R.A., Archer S.L.;
RT   "Ndufs2, a Core Subunit of Mitochondrial Complex I, Is Essential for Acute
RT   Oxygen-Sensing and Hypoxic Pulmonary Vasoconstriction.";
RL   Circ. Res. 124:1727-1746(2019).
RN   [17]
RP   INVOLVEMENT IN MC1DN6, AND VARIANTS MC1DN6 GLN-228; GLN-229 AND PRO-413.
RX   PubMed=11220739;
RX   DOI=10.1002/1531-8249(20010201)49:2<195::aid-ana39>3.0.co;2-m;
RA   Loeffen J., Elpeleg O., Smeitink J., Smeets R., Stoeckler-Ipsiroglu S.,
RA   Mandel H., Sengers R., Trijbels F., van den Heuvel L.;
RT   "Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and
RT   encephalomyopathy.";
RL   Ann. Neurol. 49:195-201(2001).
RN   [18]
RP   VARIANT VAL-224.
RX   PubMed=21057504; DOI=10.1038/ng.706;
RA   Haack T.B., Danhauser K., Haberberger B., Hoser J., Strecker V., Boehm D.,
RA   Uziel G., Lamantea E., Invernizzi F., Poulton J., Rolinski B., Iuso A.,
RA   Biskup S., Schmidt T., Mewes H.W., Wittig I., Meitinger T., Zeviani M.,
RA   Prokisch H.;
RT   "Exome sequencing identifies ACAD9 mutations as a cause of complex I
RT   deficiency.";
RL   Nat. Genet. 42:1131-1134(2010).
RN   [19]
RP   VARIANT MC1DN6 ASN-446, CHARACTERIZATION OF VARIANT MC1DN6 ASN-446,
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22036843; DOI=10.1016/j.bbadis.2011.10.012;
RA   Ngu L.H., Nijtmans L.G., Distelmaier F., Venselaar H.,
RA   van Emst-de Vries S.E., van den Brand M.A., Stoltenborg B.J., Wintjes L.T.,
RA   Willems P.H., van den Heuvel L.P., Smeitink J.A., Rodenburg R.J.;
RT   "A catalytic defect in mitochondrial respiratory chain complex I due to a
RT   mutation in NDUFS2 in a patient with Leigh syndrome.";
RL   Biochim. Biophys. Acta 1822:168-175(2012).
CC   -!- FUNCTION: Core subunit of the mitochondrial membrane respiratory chain
CC       NADH dehydrogenase (Complex I) which catalyzes electron transfer from
CC       NADH through the respiratory chain, using ubiquinone as an electron
CC       acceptor (PubMed:22036843, PubMed:28031252, PubMed:30922174). Essential
CC       for the catalytic activity of complex I (PubMed:22036843,
CC       PubMed:30922174). Essential for the assembly of complex I (By
CC       similarity). Redox-sensitive, critical component of the oxygen-sensing
CC       pathway in the pulmonary vasculature which plays a key role in acute
CC       pulmonary oxygen-sensing and hypoxic pulmonary vasoconstriction
CC       (PubMed:30922174). Plays an important role in carotid body sensing of
CC       hypoxia (By similarity). Essential for glia-like neural stem and
CC       progenitor cell proliferation, differentiation and subsequent
CC       oligodendrocyte or neuronal maturation (By similarity).
CC       {ECO:0000250|UniProtKB:Q91WD5, ECO:0000269|PubMed:22036843,
CC       ECO:0000269|PubMed:28031252, ECO:0000269|PubMed:30922174}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ubiquinone + NADH + 5 H(+)(in) = a ubiquinol + NAD(+) + 4
CC         H(+)(out); Xref=Rhea:RHEA:29091, Rhea:RHEA-COMP:9565, Rhea:RHEA-
CC         COMP:9566, ChEBI:CHEBI:15378, ChEBI:CHEBI:16389, ChEBI:CHEBI:17976,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=7.1.1.2;
CC         Evidence={ECO:0000269|PubMed:22036843, ECO:0000269|PubMed:30922174};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.2 uM for decylubiquinone {ECO:0000269|PubMed:22036843};
CC         KM=55 uM for ubiquinone-1 {ECO:0000269|PubMed:22036843};
CC   -!- SUBUNIT: Core subunit of respiratory chain NADH dehydrogenase (Complex
CC       I) which is composed of 45 different subunits. Component of the iron-
CC       sulfur (IP) fragment of the enzyme (PubMed:12611891). Interacts with
CC       NDUFAF3 (PubMed:19463981). Interacts with NDUFAF7 (PubMed:20406883,
CC       PubMed:24089531). Interacts with CERS2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q91WD5, ECO:0000269|PubMed:12611891,
CC       ECO:0000269|PubMed:19463981, ECO:0000269|PubMed:20406883,
CC       ECO:0000269|PubMed:24089531}.
CC   -!- INTERACTION:
CC       O75306; O75489: NDUFS3; NbExp=12; IntAct=EBI-1224806, EBI-1224896;
CC       O75306; Q99650: OSMR; NbExp=4; IntAct=EBI-1224806, EBI-2804080;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000305|PubMed:12611891, ECO:0000305|PubMed:9585441}; Peripheral
CC       membrane protein {ECO:0000250|UniProtKB:Q641Y2}; Matrix side
CC       {ECO:0000250|UniProtKB:Q641Y2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75306-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75306-2; Sequence=VSP_046466;
CC   -!- PTM: Dimethylation at Arg-118 by NDUFAF7 takes place after NDUFS2
CC       assembles into the complex I, leading to stabilize the early
CC       intermediate complex (PubMed:24089531, PubMed:24838397).
CC       {ECO:0000269|PubMed:24089531, ECO:0000269|PubMed:24838397}.
CC   -!- DISEASE: Mitochondrial complex I deficiency, nuclear type 6 (MC1DN6)
CC       [MIM:618228]: A form of mitochondrial complex I deficiency, the most
CC       common biochemical signature of mitochondrial disorders, a group of
CC       highly heterogeneous conditions characterized by defective oxidative
CC       phosphorylation, which collectively affects 1 in 5-10000 live births.
CC       Clinical disorders have variable severity, ranging from lethal neonatal
CC       disease to adult-onset neurodegenerative disorders. Phenotypes include
CC       macrocephaly with progressive leukodystrophy, non-specific
CC       encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh
CC       syndrome, Leber hereditary optic neuropathy, and some forms of
CC       Parkinson disease. MC1DN6 transmission pattern is consistent with
CC       autosomal recessive inheritance. {ECO:0000269|PubMed:11220739,
CC       ECO:0000269|PubMed:22036843}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Leber-like hereditary optic neuropathy, autosomal recessive 2
CC       (LHONAR2) [MIM:620569]: An autosomal recessive form of Leber hereditary
CC       optic neuropathy, a mitochondrial disease resulting in bilateral
CC       painless loss of central vision due to selective degeneration of the
CC       retinal ganglion cells and their axons. LHONAR2 is characterized by
CC       subacute bilateral or asymmetrical visual loss, optic nerve pseudoedema
CC       and peripapillary telangiectasia in the early phase of the disease, and
CC       eventual partial recovery in some patients.
CC       {ECO:0000269|PubMed:28031252}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the complex I 49 kDa subunit family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF050640; AAC27453.1; -; mRNA.
DR   EMBL; AF013160; AAC34362.1; -; mRNA.
DR   EMBL; AK314807; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL590714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52625.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52626.1; -; Genomic_DNA.
DR   EMBL; BC000170; AAH00170.1; -; mRNA.
DR   EMBL; BC001456; AAH01456.1; -; mRNA.
DR   EMBL; BC008868; AAH08868.1; -; mRNA.
DR   CCDS; CCDS1224.1; -. [O75306-1]
DR   CCDS; CCDS53404.1; -. [O75306-2]
DR   PIR; JE0193; JE0193.
DR   RefSeq; NP_001159631.1; NM_001166159.2. [O75306-2]
DR   RefSeq; NP_001364227.1; NM_001377298.1. [O75306-1]
DR   RefSeq; NP_001364228.1; NM_001377299.1. [O75306-1]
DR   RefSeq; NP_001364229.1; NM_001377300.1. [O75306-2]
DR   RefSeq; NP_001364230.1; NM_001377301.1. [O75306-2]
DR   RefSeq; NP_001364231.1; NM_001377302.1. [O75306-2]
DR   RefSeq; NP_004541.1; NM_004550.5. [O75306-1]
DR   PDB; 5XTB; EM; 3.40 A; Q=79-463.
DR   PDB; 5XTC; EM; 3.70 A; Q=34-79.
DR   PDB; 5XTD; EM; 3.70 A; Q=34-463.
DR   PDB; 5XTH; EM; 3.90 A; Q=34-463.
DR   PDB; 5XTI; EM; 17.40 A; BQ/Q=34-463.
DR   PDB; 9CWT; EM; 3.44 A; Q=1-463.
DR   PDBsum; 5XTB; -.
DR   PDBsum; 5XTC; -.
DR   PDBsum; 5XTD; -.
DR   PDBsum; 5XTH; -.
DR   PDBsum; 5XTI; -.
DR   PDBsum; 9CWT; -.
DR   AlphaFoldDB; O75306; -.
DR   EMDB; EMD-45974; -.
DR   SMR; O75306; -.
DR   BioGRID; 110800; 320.
DR   ComplexPortal; CPX-577; Mitochondrial respiratory chain complex I.
DR   CORUM; O75306; -.
DR   FunCoup; O75306; 1810.
DR   IntAct; O75306; 112.
DR   MINT; O75306; -.
DR   STRING; 9606.ENSP00000356972; -.
DR   BindingDB; O75306; -.
DR   ChEMBL; CHEMBL3039; -.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB00157; NADH.
DR   DrugCentral; O75306; -.
DR   GlyGen; O75306; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75306; -.
DR   PhosphoSitePlus; O75306; -.
DR   SwissPalm; O75306; -.
DR   BioMuta; NDUFS2; -.
DR   jPOST; O75306; -.
DR   MassIVE; O75306; -.
DR   PaxDb; 9606-ENSP00000356972; -.
DR   PeptideAtlas; O75306; -.
DR   ProteomicsDB; 49883; -. [O75306-1]
DR   Pumba; O75306; -.
DR   TopDownProteomics; O75306-1; -. [O75306-1]
DR   Antibodypedia; 34301; 317 antibodies from 33 providers.
DR   DNASU; 4720; -.
DR   Ensembl; ENST00000367993.7; ENSP00000356972.3; ENSG00000158864.14. [O75306-1]
DR   Ensembl; ENST00000392179.5; ENSP00000376018.4; ENSG00000158864.14. [O75306-2]
DR   Ensembl; ENST00000676600.1; ENSP00000503989.1; ENSG00000158864.14. [O75306-1]
DR   Ensembl; ENST00000676972.1; ENSP00000503117.1; ENSG00000158864.14. [O75306-1]
DR   Ensembl; ENST00000677457.1; ENSP00000503294.1; ENSG00000158864.14. [O75306-2]
DR   Ensembl; ENST00000677550.1; ENSP00000503353.1; ENSG00000158864.14. [O75306-2]
DR   Ensembl; ENST00000678507.1; ENSP00000504199.1; ENSG00000158864.14. [O75306-1]
DR   Ensembl; ENST00000678511.1; ENSP00000504846.1; ENSG00000158864.14. [O75306-1]
DR   Ensembl; ENST00000678605.1; ENSP00000503969.1; ENSG00000158864.14. [O75306-2]
DR   Ensembl; ENST00000679176.1; ENSP00000504170.1; ENSG00000158864.14. [O75306-2]
DR   GeneID; 4720; -.
DR   KEGG; hsa:4720; -.
DR   MANE-Select; ENST00000676972.1; ENSP00000503117.1; NM_001377299.1; NP_001364228.1.
DR   UCSC; uc001fyv.4; human. [O75306-1]
DR   AGR; HGNC:7708; -.
DR   ClinPGx; PA31519; -.
DR   CTD; 4720; -.
DR   DisGeNET; 4720; -.
DR   GeneCards; NDUFS2; -.
DR   HGNC; HGNC:7708; NDUFS2.
DR   HPA; ENSG00000158864; Tissue enhanced (skeletal muscle, tongue).
DR   MalaCards; NDUFS2; -.
DR   MIM; 602985; gene.
DR   MIM; 618228; phenotype.
DR   MIM; 620569; phenotype.
DR   OpenTargets; ENSG00000158864; -.
DR   Orphanet; 2609; Isolated complex I deficiency.
DR   Orphanet; 104; Leber hereditary optic neuropathy.
DR   VEuPathDB; HostDB:ENSG00000158864; -.
DR   eggNOG; KOG2870; Eukaryota.
DR   GeneTree; ENSGT00390000009529; -.
DR   HOGENOM; CLU_015134_1_1_1; -.
DR   InParanoid; O75306; -.
DR   OMA; TRMDYLT; -.
DR   OrthoDB; 1009at2759; -.
DR   PAN-GO; O75306; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; O75306; -.
DR   BioCyc; MetaCyc:HS08339-MONOMER; -.
DR   PathwayCommons; O75306; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   Reactome; R-HSA-6799198; Complex I biogenesis.
DR   SignaLink; O75306; -.
DR   SIGNOR; O75306; -.
DR   Agora; ENSG00000158864; Agora Nominated Target for Alzheimer's Disease.
DR   BioGRID-ORCS; 4720; 352 hits in 1168 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; NDUFS2; human.
DR   GeneWiki; NDUFS2; -.
DR   GenomeRNAi; 4720; -.
DR   Pharos; O75306; Tclin.
DR   PRO; PR:O75306; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O75306; protein.
DR   Bgee; ENSG00000158864; Expressed in apex of heart and 204 other cell types or tissues.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:ComplexPortal.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0045271; C:respiratory chain complex I; IDA:UniProtKB.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0009055; F:electron transfer activity; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0008137; F:NADH dehydrogenase (ubiquinone) activity; IMP:UniProtKB.
DR   GO; GO:0016651; F:oxidoreductase activity, acting on NAD(P)H; IEA:InterPro.
DR   GO; GO:0019826; F:oxygen sensor activity; IMP:UniProtKB.
DR   GO; GO:0048038; F:quinone binding; IEA:InterPro.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0009060; P:aerobic respiration; NAS:ComplexPortal.
DR   GO; GO:0071453; P:cellular response to oxygen levels; IMP:UniProtKB.
DR   GO; GO:0042063; P:gliogenesis; ISS:UniProtKB.
DR   GO; GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; IMP:CAFA.
DR   GO; GO:0006120; P:mitochondrial electron transport, NADH to ubiquinone; IMP:UniProtKB.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; ISS:UniProtKB.
DR   GO; GO:0061351; P:neural precursor cell proliferation; ISS:UniProtKB.
DR   GO; GO:0022008; P:neurogenesis; ISS:UniProtKB.
DR   GO; GO:0042776; P:proton motive force-driven mitochondrial ATP synthesis; NAS:ComplexPortal.
DR   FunFam; 1.10.645.10:FF:000005; NADH-quinone oxidoreductase subunit D; 1.
DR   Gene3D; 1.10.645.10; Cytochrome-c3 Hydrogenase, chain B; 1.
DR   HAMAP; MF_01358; NDH1_NuoD; 1.
DR   InterPro; IPR001135; NADH_Q_OxRdtase_suD.
DR   InterPro; IPR014029; NADH_UbQ_OxRdtase_49kDa_CS.
DR   InterPro; IPR022885; NDH1_su_D/H.
DR   InterPro; IPR029014; NiFe-Hase_large.
DR   NCBIfam; TIGR01962; NuoD; 1.
DR   NCBIfam; NF004739; PRK06075.1; 1.
DR   PANTHER; PTHR11993:SF10; NADH DEHYDROGENASE [UBIQUINONE] IRON-SULFUR PROTEIN 2, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR11993; NADH-UBIQUINONE OXIDOREDUCTASE 49 KDA SUBUNIT; 1.
DR   Pfam; PF00346; Complex1_49kDa; 1.
DR   SUPFAM; SSF56762; HydB/Nqo4-like; 1.
DR   PROSITE; PS00535; COMPLEX1_49K; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Acetylation; Alternative splicing; Disease variant;
KW   Electron transport; Iron; Iron-sulfur; Leber hereditary optic neuropathy;
KW   Membrane; Metal-binding; Methylation; Mitochondrion;
KW   Mitochondrion inner membrane; NAD; Oxidoreductase;
KW   Primary mitochondrial disease; Proteomics identification;
KW   Reference proteome; Respiratory chain; Transit peptide; Translocase;
KW   Transport; Ubiquinone.
FT   TRANSIT         1..33
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000250|UniProtKB:P17694"
FT   CHAIN           34..463
FT                   /note="NADH dehydrogenase [ubiquinone] iron-sulfur protein
FT                   2, mitochondrial"
FT                   /id="PRO_0000019981"
FT   BINDING         326
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255"
FT   BINDING         332
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255"
FT   BINDING         347
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91WD5"
FT   MOD_RES         118
FT                   /note="Symmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:24089531,
FT                   ECO:0000269|PubMed:24838397"
FT   VAR_SEQ         454..463
FT                   /note="QDIVFGEVDR -> RPIV (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046466"
FT   VARIANT         20
FT                   /note="P -> T (in dbSNP:rs11538340)"
FT                   /id="VAR_034150"
FT   VARIANT         53
FT                   /note="Y -> C (in LHONAR2; likely pathogenic; functional
FT                   testing in a yeast model shows decreased NADH dehydrogenase
FT                   (ubiquinone) activity)"
FT                   /evidence="ECO:0000269|PubMed:28031252"
FT                   /id="VAR_089158"
FT   VARIANT         224
FT                   /note="A -> V"
FT                   /evidence="ECO:0000269|PubMed:21057504"
FT                   /id="VAR_071891"
FT   VARIANT         228
FT                   /note="R -> Q (in MC1DN6; dbSNP:rs121434427)"
FT                   /evidence="ECO:0000269|PubMed:11220739"
FT                   /id="VAR_019535"
FT   VARIANT         229
FT                   /note="P -> A (in dbSNP:rs16827493)"
FT                   /id="VAR_034151"
FT   VARIANT         229
FT                   /note="P -> Q (in MC1DN6; dbSNP:rs121434428)"
FT                   /evidence="ECO:0000269|PubMed:11220739"
FT                   /id="VAR_019536"
FT   VARIANT         308
FT                   /note="Y -> C (in LHONAR2; likely pathogenic; functional
FT                   testing in a yeast model shows decreased NADH dehydrogenase
FT                   (ubiquinone) activity)"
FT                   /evidence="ECO:0000269|PubMed:28031252"
FT                   /id="VAR_089159"
FT   VARIANT         352
FT                   /note="P -> A (in dbSNP:rs11576415)"
FT                   /id="VAR_034152"
FT   VARIANT         413
FT                   /note="S -> P (in MC1DN6; dbSNP:rs121434429)"
FT                   /evidence="ECO:0000269|PubMed:11220739"
FT                   /id="VAR_019537"
FT   VARIANT         446
FT                   /note="D -> N (in MC1DN6; loss of catalytic activity; no
FT                   change in Km value for ubiquinone-1)"
FT                   /evidence="ECO:0000269|PubMed:22036843"
FT                   /id="VAR_084193"
FT   CONFLICT        24
FT                   /note="V -> G (in Ref. 2; AAC34362)"
FT                   /evidence="ECO:0000305"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   TURN            89..94
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          96..105
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          107..112
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           120..125
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           129..132
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           134..137
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          140..142
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           145..158
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           165..193
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           198..218
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          219..223
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          231..234
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           240..249
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           251..259
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   TURN            260..264
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           266..272
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           280..286
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           291..294
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   TURN            295..297
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           310..312
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          318..320
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           326..349
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   TURN            361..363
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           368..371
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           375..384
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   TURN            385..387
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          393..402
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          405..413
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   STRAND          415..423
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           427..439
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           444..453
FT                   /evidence="ECO:0007829|PDB:5XTB"
FT   HELIX           458..461
FT                   /evidence="ECO:0007829|PDB:5XTB"
SQ   SEQUENCE   463 AA;  52546 MW;  A2BF56F008B6312C CRC64;
     MAALRALCGF RGVAAQVLRP GAGVRLPIQP SRGVRQWQPD VEWAQQFGGA VMYPSKETAH
     WKPPPWNDVD PPKDTIVKNI TLNFGPQHPA AHGVLRLVME LSGEMVRKCD PHIGLLHRGT
     EKLIEYKTYL QALPYFDRLD YVSMMCNEQA YSLAVEKLLN IRPPPRAQWI RVLFGEITRL
     LNHIMAVTTH ALDLGAMTPF FWLFEEREKM FEFYERVSGA RMHAAYIRPG GVHQDLPLGL
     MDDIYQFSKN FSLRLDELEE LLTNNRIWRN RTIDIGVVTA EEALNYGFSG VMLRGSGIQW
     DLRKTQPYDV YDQVEFDVPV GSRGDCYDRY LCRVEEMRQS LRIIAQCLNK MPPGEIKVDD
     AKVSPPKRAE MKTSMESLIH HFKLYTEGYQ VPPGATYTAI EAPKGEFGVY LVSDGSSRPY
     RCKIKAPGFA HLAGLDKMSK GHMLADVVAI IGTQDIVFGE VDR
//
